检索

Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study

Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.

(Rus)

卷 30, 编号 3 (2023)

Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination

Biryukova E., Shinkin M., Morozova I.

(Rus)

卷 30, 编号 3 (2023)

Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series

Smirnova E.

(Rus)

Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin

Biryukova E.

(Rus)

Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus

Demidov N.

(Rus)

The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus

Petrov V., Shatalova O., Klykova M., Stetsky N.

(Rus)

Screening, diagnosis and treatment of early carbohydrate metabolism disorders

Demidova I., Boeva V.

(Rus)

Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection

Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.

(Rus)

Vildagliptin – 15 years in active service with diabetologists

Pavlova M.

(Rus)

Analysis of the quality of clinical follow-up care of patients with type 2 diabetes mellitus

Demicheva T.

(Rus)

Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice

Elsukova O., Nikitina E., Chuprova A., Kaysina O.

(Rus)

Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus

Smirnova E.

(Rus)

Modern possibilities for assessing glycemia in diabetic patients

Chernikova N., Degtyareva E.

(Rus)

Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age

Markina J.

(Rus)

The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow

Antsiferov M., Antsiferova D., Koteshkova O., Demidov N.

(Rus)

Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution

Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.

(Rus)

How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary

Astamirova K., Gatina A., Gorbunova Y., Demidov N., Ivanenko T., Kolesnikova M., Lapteva O., Morozova I., Parshina V., Presnyakova O., Smirnova E., Smirnova N., Startseva M., Khamrazhanov Z., Kholmskaya N.

(Rus)

Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation

Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.

(Rus)

编号 20 (2014)

Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta

Gromova O., Torshin I., Limanova O., Grishina T., Gromov A.

(Rus)

News of medicine

Kudinova S.

(Rus)

卷 28, 编号 4 (2021)

Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice

Antsiferov M., Zilov A., Koteshkova O., Demidov N.

(Rus)

卷 28, 编号 4 (2021)

Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus

Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.

(Rus)

编号 11 (2012)

Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya

Mayorov A.

(Rus)

编号 5 (2017)

PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS

Ametov A.

(Rus)

编号 10 (2012)

Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii

Ametov A., Valitov B., Chernikova N., Antsiferov M.

(Rus)

卷 28, 编号 4 (2021)

Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus

Chernikova N., Knyshenko O., Ivanova L.

(Rus)

编号 16 (2013)

Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov

Ushkalova E.

(Rus)

Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus

Antsiferov M., Koteshkova O., Novikova M., Demidov N.

(Rus)

卷 27, 编号 4 (2020)

Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?

Abdullaev A., Litvinova D., Rozhkov N., Kiyaev A.

(Rus)

编号 5 (2017)

CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Chemikova N.

(Rus)

编号 5 (2013)

SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA

Verbovoy A., Sharonova L., Verbovaya N., Demidova D., Kapishnikov A.

(Rus)

编号 5 (2015)

Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa

Demidova T.

(Rus)

编号 16 (2010)

SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Mkrtumyan A., Mkrtumyan A.

卷 29, 编号 4 (2022)

Type 3 diabetes mellitus: is there a chance to become famous?

Morgunov L.

(Rus)

编号 3 (2012)

DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE

Peterkova V., Peterkova V.

编号 3 (2012)

SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS

Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.

卷 29, 编号 11/12 (2022)

Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review

Petunina N., Martirosyan N., Valeeva F.

(Rus)

Obesity: an invisible disease

Verbovoy A., Dolgikh Y., Verbovaya N., Lomonova T.

(Rus)

卷 26, 编号 14 (2019)

Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance

Ametov A., Tertychnaya E.

(Rus)

Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice

Markova T.

(Rus)

The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)

Antsiferov M., Kvasnikov B.

(Rus)

编号 11 (2018)

Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus

Sorokina Y., Zanozin A., Zanozina O., Runov G.

(Rus)

编号 16 (2016)

Modern approaches to the treatment of patients with type 2 diabetes mellitus

Antsiferov M., Fadeev V., Morgunova T.

(Rus)

编号 5 (2015)

Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa

Antsiferov M.

(Rus)

编号 16 (2014)

Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa

Verbovoy A., Sharonova L., Akhmerova R.

(Rus)

编号 16 (2013)

Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa

Statsenko M., Derevyanchenko M.

(Rus)

编号 10 (2013)

Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa

Demidova I., Boeva V.

(Rus)

编号 16 (2012)

Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?

Antsiferov M., Galstyan G.

(Rus)

编号 7 (2012)

DPP-4 INHIBITORS: TODAY AND TOMORROW. WHAT WE EXPECT FROM INCRETIN-STIMULATING THERAPY?

Antsiferov M., Ametov A., Zilov A., Antsiferov M., Ametov A., Zilov A.

编号 3 (2012)

SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Nikonova T., Nikonova T.

编号 16 (2011)

DIABETON MB IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PREVENTION OF ITS LATE COMPLICATIONS

Kononenko I., Smirnova O., Smirnova O., Kononenko I.

编号 16 (2010)

ASSESSMENT OF EFFICACY OF EDUCATION OF GENERAL PRACTITIONERS BY THE TRAINING PROGRAM FOR MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Yu Mayorov A., Surkova Y., Dedov I., Mayorov A., Surkova E., Dedov I.

编号 16 (2010)

ETIOPTHOGENIC ROLE OF INSULIN RESISTANCE IN THE DEVELOPMENT OF METABOLIC AND VASCULAR DISORDERS IN TYPE 2 DIABETES MELLITUS

Demidova T., Demidova T.

编号 3 (2010)

Innovative approaches to the treatment of type 2 diabetes mellitus: the role of specialized product for enteral nutrition "Glucerna SR"

Sharafetdinov K., Plotnikova O., Sharafetdinov K., Plotnikova O.

卷 29, 编号 4 (2022)

Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin

Novikova M., Koteshkova O., Antsiferov M.

(Rus)

Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics

Shorokhova P., Baranov V.

(Rus)

卷 27, 编号 12 (2020)

Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial

Shkurova N., Baranova N., Fedin A.

(Rus)

Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?

Biryukova E., Solovyova I.

(Rus)

编号 11 (2018)

Apelin: biological and pathophysiological effects

Dolgikh Y., Verbovoy A.

(Rus)

编号 5 (2016)

EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS

Biryukova E.

(Rus)

编号 17 (2015)

Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike

Demidov N., Zakharova S., Zav'yalov A.

(Rus)

编号 5 (2014)

VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA

Abaeva M., Nazhmutdinova P., Ametov A.

(Rus)

编号 16 (2013)

Dolgosrochnaya bezopasnost' i effektivnost' insulina aspart u patsientov s sakharnym diabetom 1 tipa

Antsiferov M.

(Rus)

编号 5 (2013)

SOSTOYaNIE KOSTNOY TKANI PRI SAKhARNOM DIABETE 2 TIPA

Ruyatkina L., Lomova A., Ruyatkin D.

(Rus)

编号 3 (2012)

HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?

Biryukova E., Antsiferov M., Biryukova Y., Antsiferov M.

编号 3 (2011)

CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS

Antsiferov M., Antsiferov M.

编号 16 (2010)

POSSIBILITY OF CORRECTION OF OXIDATIVE STRESS IN PATIENTS WITH DIABETES USING DIBICOR

Zanozina O., Zanozina O.

编号 16 (2010)

POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY

Antsiferov M., Zilov A., Antsiferov M., Zilov A.

卷 29, 编号 11/12 (2022)

Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study

Antsiferov M., Demidov N., Safronova T., Mishra O.

(Rus)

卷 29, 编号 4 (2022)

The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women

Apetov S., Apetova V.

(Rus)

School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus

Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.

(Rus)

The place of glyflozins in the management of type 2 diabetes mellitus

Sharonova L., Verbovoy A.

(Rus)

编号 11 (2018)

Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use

Biryukova E.

(Rus)

编号 16 (2017)

Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus

Tsvetkova I., Kaukova A., Belyakova N., Vasyutkova O., Konovalova O., Lareva A.

(Rus)

编号 17 (2015)

Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy

Verbovoy A., Tsanava I., Verbovaya N.

(Rus)

编号 5 (2014)

UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa

Antsiferov M., Koteshkova O.

(Rus)

编号 5 (2014)

TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA

Kudinov V., Nichitenko M., Chesnikova A.

(Rus)

编号 16 (2013)

Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki

Chernikova N., Ametov A., Antsiferov M.

(Rus)

编号 5 (2013)

PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa

Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.

(Rus)

编号 11 (2012)

Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya

Shilov A., Abdullaeva A.

(Rus)

编号 7 (2012)

DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW

Antsiferov M., Antsiferov M.

编号 3 (2012)

SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?

Kononenko I., Smirnova O., Smirnova O., Kononenko I.

编号 16 (2011)

SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Petunina N., Brashchenkova A., Petunina N., Brashcenkova A.

编号 16 (2010)

PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES

Rudakova A., Rudakova A.

P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy

Chernikova N.

(Rus)

卷 28, 编号 3 (2021)

The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine

Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.

(Rus)

卷 27, 编号 12 (2020)

Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study

Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.

(Rus)